Vir Biotechnology, Inc. VIR Noncash lease expense
Noncash lease expense at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept vir:NoncashLeaseExpense.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s noncash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s noncash lease expense?
- Vir Biotechnology, Inc. (VIR) reported noncash lease expense of $1.34M in Q1 2026.
- How has Vir Biotechnology, Inc.'s noncash lease expense changed year-over-year?
- Vir Biotechnology, Inc.'s noncash lease expense increased by 19.4% year-over-year, from $1.12M to $1.34M.
- What is the long-term trend for Vir Biotechnology, Inc.'s noncash lease expense?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s noncash lease expense has grown at a -5.2% compound annual growth rate (CAGR), from $6.17M to $4.98M.
- What does noncash lease expense mean?
- This represents the portion of lease expenses recognized in the income statement that does not involve an immediate cash outflow. It is added back to net income to reconcile to cash flow from operations under accounting standards for right-of-use assets. This metric helps analysts isolate the actual cash impact of lease obligations from accounting-based expense recognition.